Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jason Schwartz . (2020). Interview with Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005882&aid=10.1056%2FNEJMp2029479&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Nuevo objetivo “universal” para el tratamiento antiviral

Con nuevos virus que representan una amenaza...

La inteligencia artificial produce nuevos antibióticos

Investigadores del Instituto de Tecnología de...

Antibiotic resistance: World on cusp of ‘post antibiotic era’

The world is on the cusp of a "post-antibiotic...

La contaminación plástica puede estar extendiendo la resistencia a los antibióticos

Según una nueva investigación, compartida por la...

La resistencia a los antibióticos puede extenderse en ausencia de medicamentos.

Medical News Today informó recientemente sobre...

Super bacterias mortales destruidas por ejercicios moleculares

Investigadores de la Universidad de Rice, la...

Knee replacement in folks over 80: Less risky than you think

Knee replacement in folks over 80: Less risky...

Principal causes for hospital readmission identified

A group of physicians in Canada examined a...